Merck

Pfizer, Merck and Johnson & Johnson shifting profits to avoid billions in tax payments each year: report
Fierce Pharma
Thu, 09/20/18 - 12:06 pm
taxes
Pfizer
Merck
JNJ
Abbott Labs
Merck follows Opdivo’s suit, prices Keytruda in China at half its U.S. tag
Fierce Pharma
Wed, 09/19/18 - 11:53 am
drug pricing
China
Merck
Keytruda
Bristol-Myers Squibb
Opdivo
Merck to file for new use for antibiotic Zerbaxa
Pharmaforum
Tue, 09/11/18 - 11:47 am
Merck
Zerbaxa
hospital-acquired bacterial pneumonia
Merck's Keytruda clocks up new win as EU approves chemo cocktail
Yahoo/Reuters
Mon, 09/10/18 - 09:38 am
Merck
Keytruda
Europe
advanced non-squamous non-small cell lung cancer
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
CP Wire
Wed, 09/5/18 - 10:15 am
China
Eisai
Merck
Lenvima
liver cancer
HCC
Eisai and Merck Announce China Approval of Lenvima for Treatment of Unresectable Hepatocellular Carcinoma
Wed, 09/5/18 - 09:25 am
Eisai
Merck
Lenvima
liver cancer
hepatocellular carcinoma
Merck's Keytruda threatens Pfizer, Merck KGaA's Bavencio with Merkel cell 'priority' tag
Fierce Pharma
Tue, 09/4/18 - 11:05 am
Merck
Keytruda
Pfizer
Merck KGaA
Bavencio
Merkel cell carcinoma
FDA
FDA Approves Eight Novel Drugs in August
BioSpace
Sat, 09/1/18 - 04:17 pm
Kyowa Hakko Kirin
Poteligeo
Alnylam
Onpattro
Amicus Therapeutics
Galafold
TherapeuticMD
Annovera
Biocodex
Diacomit
Dompe Group
Oxervate
Shire
Takhzyro
Merck
Pifeltro
FDA approves two new HIV drugs from Merck
Reuters
Fri, 08/31/18 - 10:57 am
Merck
HIV
FDA
Delstrigo
Pifeltro
Merck’s Experimental Ebola Vaccine Seeing Wide Use in Outbreak
Bloomberg
Thu, 08/30/18 - 10:27 am
Merck
vaccines
ebola virus
Esperion's Cholesterol Combo Pill Cuts Bad Cholesterol 35%
Forbes
Mon, 08/27/18 - 10:00 am
Esperion Therapeutics
bempedoic acid
statins
Zetia
Merck
cholesterol
HPV-related cancer rises, despite higher vaccination rates
Bizjournals.com
Fri, 08/24/18 - 11:13 am
vaccines
HPV
cervical cancer
Merck
Gardasil
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
CP WIre
Thu, 08/23/18 - 10:20 am
Eisai
Merck
Lenvima
hepatocellular carcinoma
Europe
European Commission Approves New First Line Treatment for Advanced or Unresectable Hepatocellular Carcinoma – First in a Decade
Thu, 08/23/18 - 10:09 am
Eisai
Merck
Lenvima
hepatocellular carcinoma
No Ovarian Failure Risk After HPV Vaccine, Study Finds
Forbes
Wed, 08/22/18 - 10:10 am
vaccines
HPV
Gardasil
Merck
CDC
primary ovarian insufficiency
FDA gives Merck ‘real-time’ OK for Keytruda, offering a peek at the latest extension of the agency’s data express highway
Endpoints
Tue, 08/21/18 - 10:19 am
Keytruda
Merck
non-squamous non-small cell lung cancer
FDA
Eisai-Merck partnership picks up first-line Lenvima approval
Biopharma Dive
Tue, 08/21/18 - 10:16 am
FDA
Eisai
Merck
Lenvima
hepatocellular carcinoma
Merck, Geisinger gear up to market their own EHR drug-tracking apps
Fierce Biotech
Thu, 08/16/18 - 10:20 am
Merck
Geisinger
EHRs
mobile apps
patients
patient adherence
digital health
devices
Merck, GSK, BIO and Pew Comment on Draft Guidance on LPAD Approval Pathway
RAPS.org
Wed, 08/15/18 - 10:30 pm
Merck
GSK
BIO
Pew Charitable Trusts
LPAD pathway
Merck’s 60% price cut for hepatitis C drug nets company a big sales opportunity
Marketwatch
Wed, 08/8/18 - 12:00 am
Merck
Express Scripts
hepatitis C
Zepatier

Pages